Back to results
US 9,956,209 B2Granted
Compounds αv β6 integrin antagonists
AssigneeGlaxoSmithKline Intellectual Property Development Limited
InventorsNiall Andrew Anderson, Matthew Howard James Campbell-Crawford, Ashley Paul Hancock, John Martin Pritchard, Joanna Mary Redmond
Life of this patent
Estimating the term…
Abstract
A compound of formula (I): which is 4-(3-fluoro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)-3-(3-(2-methoxyethoxy)phenyl)butanoic acid, or a salt thereof.
Claims10
A compound of formula (I) which is 4-(3-fluoro-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)-3-(3-(2-methoxyethoxy)phenyl)butanoic acid
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.